- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04726722
Evaluation of a Personcentered Internet-based CBT Program for Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease
Evaluation of an Adaptable and Personcentered Internet-based CBT Program Aimed to Treat Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All patients diagnosed as CVD (i.e. diagnosis Ischemia (ICD-code I20., I25.), Heart Failure (ICD-code I50., I42.) or Arrhythmia (ICD-code I48, I49, DF016) and who received care in the last 12 months at hospitals in the south-east of Sweden will be contacted by letter with information about the study.
Participants who are interested are invited to visit our website for more information, registration and provision of informed consent. After registration, participants will respond to questions about demographics, medical history, stress, anxiety and depressive symptoms on the website. Inclusion or exclusion will be assessed by a group consisting of a psychologist, cardiology specialist nurse and a psychiatry specialist nurse.
Before final inclusion and randomization eligible participants will be contacted for a telephone interview held by the study nurses.
Included (n=400) participants will, on our website (www.xxxxxx), complete the baseline study questionnaires and then be randomized according to a 2 x2 factorial design.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Peter Johansson, Ph.D
- Phone Number: +46-070 08 96548
- Email: peter.b.johansson@liu.se
Study Locations
-
-
Linköpings Universitet
-
Norrköping, Linköpings Universitet, Sweden, 601 74
- Recruiting
- Peter Johansson
-
Contact:
- Peter Johansson, Professor
- Phone Number: +46460700896548
- Email: peter.b.johansson@liu.se
-
Contact:
- Johan Lundgren, PhD
- Email: johan.lundgren@liu.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 18 years and above
- treatment for cardiovascular disease (CVD) according to European Society of Cardiology guidelines
- stable CVD (New York Heart Association class I-III) and not having been hospitalised for CVD in in the last four weeks.
- stress (Perceived Stress Scale (PSS)-10>13 points) and/or
- anxiety (i.e. General Anxiety Disorder Scale (GAD) ≥5 points) and/or
- depressive symptoms (Patient Health Questionnaire-9 28 (PHQ-9) > 5 points)
Exclusion Criteria:
- severe CVD (New York Heart Association classification IV) or another severe chronic life-threatening disease
- severe stress, anxiety or depression assessed as requiring acute treatment
- not being able to dedicate 3-4 hours per week to participate in the program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Design of the CBT treatment content
Patient determined CBT content (i.e.
person-centered) vs. therapist determined I-CBT content
|
When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules. Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired |
Experimental: Control of support and feedback
Patient-controlled support and feedback (person-centred) vs. therapist -controlled.
|
When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules. Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in stress from baseline to 9 weeks on the 10 item Perceived Stress Scale
Time Frame: From baseline to 9 weeks at the end of the intervention.
|
The 10-item Perceived Stress Scale is a valideted self-report of Stress.
The instreument measures the degree to which individuals perceives their life situations as stressful.
The 10 items are rated on a 5 point scale and higher scores means more stress
|
From baseline to 9 weeks at the end of the intervention.
|
Change in anxiety from baseline to 9 weeks on the 7-item Generalized Anxiety Disorder Scale.
Time Frame: From baseline to 9 weeks at the end of the intervention.
|
General Anxiety Disorder scale is validagted self-resport that measure symptoms of general anxiety during the last two weeks.
The 7-items range from 0 (not bothered at all) to 3 (nearly every day).
A higher score indicate more anxiety and the cut-off 5 suggests at least mild anxiety.
|
From baseline to 9 weeks at the end of the intervention.
|
Change in depressive symptoms from baseline to 9 weeks on the 9 item Patient Health Questionnaire.
Time Frame: From baseline to 9 weeks at the end of the intervention.
|
The 9-item Patient Health Questionnaire is a validated self-report that measure depressive symtpoms during the last two weeks.
Each item is answered on a four graded scale where 0 means that the person not is affected and 3 where the person is affected several Days to almost every day.
Higher numbers represents higher levels of depressive symptoms.
A cut-off >5 represents at least mild depression.
|
From baseline to 9 weeks at the end of the intervention.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Peter Johansson, Ph.D, Department of Health, Medicine and Caring Sciences, Linkoping University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-00935
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Morehouse School of MedicineNot yet recruiting
-
Yonsei UniversityRecruitingCardiovascular DiseaseKorea, Republic of
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
National Human Genome Research Institute (NHGRI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States
Clinical Trials on internet-based cognitive behavioral theraphy
-
Karolinska InstitutetCompletedObsessive-compulsive DisorderSweden
-
University of TromsoUnknownComplicated Grief
-
Karolinska InstitutetUppsala UniversityRecruiting
-
Montefiore Medical CenterRecruitingInflammatory Bowel Diseases | Psychological DistressUnited States
-
The Netherlands Cancer InstituteDutch Cancer Society; Pink Ribbon Inc.CompletedSexual Dysfunction | Breast Cancer Survivors | Intimacy ProblemsNetherlands
-
Karolinska InstitutetCompleted
-
Linkoeping UniversityActive, not recruitingDepressive Symptoms | Anxiety SymptomsSweden
-
Linkoeping UniversityActive, not recruitingAnxiety Symptoms | Depression SymptomsSweden
-
Karolinska InstitutetDeakin UniversityRecruiting
-
Umeå UniversityCompleted